The anticancer efficacy of paclitaxel liposomes modified with low-toxicity hydrophobic cell-penetrating peptides in breast cancer: an in vitro and in vivo evaluation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The anticancer efficacy of paclitaxel liposomes modified with low-toxicity hydrophobic cell-penetrating peptides in breast cancer: an in vitro and in vivo evaluation
Authors
Keywords
-
Journal
RSC Advances
Volume 8, Issue 43, Pages 24084-24093
Publisher
Royal Society of Chemistry (RSC)
Online
2018-07-03
DOI
10.1039/c8ra03607a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
- (2017) Jiawei Sun et al. International Journal of Nanomedicine
- Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts
- (2017) Yuanyuan Shen et al. International Journal of Nanomedicine
- Self-assembled liposomes of dual paclitaxel-phospholipid prodrug for anticancer therapy
- (2017) Longbing Ling et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Cell-penetrating peptides with intracellular organelle targeting
- (2016) Carmine Pasquale Cerrato et al. Expert Opinion on Drug Delivery
- The Use of a Hydrophobic Binding Peptide Modified Lipid Nanocarrier Improving Tumor Distribution and Antitumor Efficacy
- (2016) Wei Gao et al. Journal of Biomedical Nanotechnology
- Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation
- (2016) Fatemeh Ravar et al. JOURNAL OF CONTROLLED RELEASE
- A nanomedicine based combination therapy based on QLPVM peptide functionalized liposomal tamoxifen and doxorubicin against Luminal A breast cancer
- (2016) Xiaoyou Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response
- (2015) Lei Jiang et al. BIOMATERIALS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Multi-functional liposomes showing radiofrequency-triggered release and magnetic resonance imaging for tumor multi-mechanism therapy
- (2015) Bin Du et al. Nanoscale
- Cell-Penetrating Peptides: Design, Synthesis, and Applications
- (2014) Dana Maria Copolovici et al. ACS Nano
- A synergistic combination therapy with paclitaxel and doxorubicin loaded micellar nanoparticles
- (2014) Yan Wang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Functional Nanoparticles in Targeting Glioma Diagnosis and Therapies
- (2014) Minghui Li et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Clinical Comparison between Paclitaxel Liposome (Lipusu®) and Paclitaxel for Treatment of Patients with Metastatic Gastric Cancer
- (2013) Xu Xu et al. Asian Pacific Journal of Cancer Prevention
- Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy
- (2013) Defu Cai et al. BIOMATERIALS
- Paclitaxel drug delivery systems
- (2013) Zhiping Zhang et al. Expert Opinion on Drug Delivery
- Current trends in the use of liposomes for tumor targeting
- (2013) Pranali P Deshpande et al. Nanomedicine
- 2′-Behenoyl-paclitaxel conjugate containing lipid nanoparticles for the treatment of metastatic breast cancer
- (2012) Ping Ma et al. CANCER LETTERS
- Paclitaxel in Cancer Treatment: Perspectives and Prospects of its Delivery Challenges
- (2012) Somnath Singh et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Treatment of metastatic breast cancer: State-of-the-art, subtypes and perspectives
- (2011) Nagi S. El Saghir et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Fibroblast Growth Factor-12 (FGF12) Translocation into Intestinal Epithelial Cells Is Dependent on a Novel Cell-penetrating Peptide Domain
- (2011) Fumiaki Nakayama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
- (2011) Twan Lammers et al. JOURNAL OF CONTROLLED RELEASE
- Spontaneous Membrane-Translocating Peptides by Orthogonal High-Throughput Screening
- (2011) Jessica R. Marks et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Complexation and conjugation approaches to evaluate siRNA delivery using cationic, hydrophobic and amphiphilic peptides
- (2011) Jung Woo Park et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
- (2010) Chunbai He et al. BIOMATERIALS
- Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines
- (2010) Seyedeh Parinaz Akhlaghi et al. Nanomedicine-Nanotechnology Biology and Medicine
- Impact of Nanotechnology on Drug Delivery
- (2009) Omid C. Farokhzad et al. ACS Nano
- Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD
- (2009) Catherine L. Watkins et al. JOURNAL OF CONTROLLED RELEASE
- Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery
- (2009) Emily Gullotti et al. MOLECULAR PHARMACEUTICS
- Recent Developments in Taxane Drug Delivery
- (2008) Ahmad Safavy Current Drug Delivery
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started